NCT00169143 - Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Untreated CD20-positive Large B-cell Lymphoma

Interventions

DRUG

Rituximab + ACVBP regimen plus Pegfilgrastim

PROCEDURE

Autologous stem cell transplant

Trial Locations (6)

Hôpital Henri Mondor, Créteil

Service d'Hématologie Clinique - CHU Le Bocage, Dijon

Hôpital Saint Louis, Paris

Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite

Centre Henri Becquerel, Rouen

CHRU de Nancy Brabois, Vandœuvre-lès-Nancy